Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Loss And Total Comprehensive Income Attributable Of RMB32.8 Million
Aug 26 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* HY LOSS AND TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE
RMB32.8
MILLION LOSS OF RMB507.0 MILLION
* REVENUE WAS RMB1,293.3 MILLION FOR SIX MONTHS, INCREASE OF
539.5%
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million